Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)

Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study

(2016) Philip A. Thompson et al.   BRITISH JOURNAL OF HAEMATOLOGY

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

(2016) Barbara Eichhorst et al.   LANCET ONCOLOGY

Response: Additional data needed for a better understanding of the potential relationship between atrial fibrillation and ibrutinib

(2015) J. C. Byrd et al.   BLOOD

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study

(2015) E. Svennberg et al.   CIRCULATION

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

(2015) Mohammed Z H Farooqui et al.   LANCET ONCOLOGY

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

(2015) Jan A. Burger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling

(2014) J. R. McMullen et al.   BLOOD

Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia

(2014) N. Pflug et al.   BLOOD

Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines

(2014) Timothy G. Call et al.   CANCER

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials

(2014) V. Goede et al.   HAEMATOLOGICA

Ibrutinib Resistance in Chronic Lymphocytic Leukemia

(2014) Richard R. Furman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

(2014) Valentin Goede et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

(2014) John C. Byrd et al.   NEW ENGLAND JOURNAL OF MEDICINE

Worldwide Epidemiology of Atrial Fibrillation

(2013) Sumeet S. Chugh et al.   CIRCULATION

Atrial fibrillation prevalence revisited

(2013) L. Friberg et al.   JOURNAL OF INTERNAL MEDICINE

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial

(2013) Susan O'Brien et al.   LANCET ONCOLOGY

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

(2013) John C. Byrd et al.   NEW ENGLAND JOURNAL OF MEDICINE

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

(2013) Alvaro Alonso et al.   Journal of the American Heart Association

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (from the Atherosclerosis Risk In Communities [ARIC] Study)

(2010) Alanna M. Chamberlain et al.   AMERICAN JOURNAL OF CARDIOLOGY

Validation of an Atrial Fibrillation Risk Algorithm in Whites and African Americans

(2010) Renate B. Schnabel et al.   ARCHIVES OF INTERNAL MEDICINE

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation

(2009) Lynette Pretorius et al.   AMERICAN JOURNAL OF PATHOLOGY

Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience

(2009) P. Abrisqueta et al.   BLOOD

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

(2009) B. F. Eichhorst et al.   BLOOD

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

(2009) L. Friberg et al.   EUROPEAN HEART JOURNAL

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

(2009) Renate B Schnabel et al.   LANCET

Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

(2008) Paul Thurmes et al.   LEUKEMIA & LYMPHOMA